Company chart and information is provided by TradingView based on 15-minute-delayed data.
NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Geographically operates through the region of the United States.
| Website: | www.nucana.com |
| Email: | info@nucana.com |
| Main Phone: | +44 1313571111 |
| Address: | 3 Lochside Way |
| City / Town: | Edinburgh |
| Country: | GB |
| Postal Code: | EH12 9DT |
| Exchange: | NGS |
| CEO: | Hugh Griffith |
| Employees: | 29 |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
